Yeast as a model for studying Alzheimer's disease

QR Code

Yeast as a model for studying Alzheimer's disease

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by acute cognitive decline. The AD brain is featured by extracellular senile amyloid plaques, intraneuronal neurofibrillary tangles and extensive neuronal cell loss in specific regions of the brain associated wit...

Full description

Bibliographic Details
Main Authors:	Bharadwaj, Prashant, Martins, R., Macreadie, I.
Format:	Journal Article
Published:	Wiley-Blackwell 2010
Online Access:	http://hdl.handle.net/20.500.11937/18591

Similar Items

Alzheimer's amyloid-ß rescues yeast from hydroxide toxicity
by: Dubey, A., et al.
Published: (2009)

Aß aggregation and possible implications in Alzheimer's disease pathogenesis
by: Bharadwaj, Prashant, et al.
Published: (2009)

A yeast model for studying intracellular clearance of beta-amyloid 42
by: Bharadwaj, Prashant, et al.
Published: (2012)

Finding chemopreventatives to reduce amyloid beta in yeast
by: Macreadie, I., et al.
Published: (2016)

Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease
by: Martins, I.j, et al.
Published: (2009)

The Role of Luteinizing Hormone in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2010)

Latrepirdine enhances Aß degradation in yeast via an autophagic pathway
by: Bharadwaj, Prashant, et al.
Published: (2010)

Zebrafish as a tool in Alzheimer's disease research
by: Newman, M., et al.
Published: (2011)

Role of the cell membrane interface in modulating production and uptake of Alzheimer's beta amyloid protein
by: Bharadwaj, Prashant, et al.
Published: (2018)

Animal Models of Alzheimer's Disease
by: Newman, M., et al.
Published: (2017)

Models of Alzheimer’s Disease
by: Chen, M., et al.
Published: (2014)

The Link Between Diabetes, Glucose Control, and Alzheimer's Disease and Neurodegenerative Diseases
by: Verdile, Giuseppe, et al.
Published: (2019)

The role of gonadotoprins in Alzheimer’s disease: potential neurodegenerative mechanisms
by: Barron, A., et al.
Published: (2006)

Reproductive Hormones Modulate Oxidative Stress in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2006)

The role of dietary coconut for the prevention and treatment of Alzheimer's disease: potential mechanisms of action
by: Fernando, W., et al.
Published: (2015)

Latrepirdine: Molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases
by: Bharadwaj, P., et al.
Published: (2013)

Latrepirdine (Dimebon™) enhances autophagy and reduces intracellular GFP-A42 levels in yeast
by: Bharadwaj, P., et al.
Published: (2012)

Immunization in Alzheimer’s disease: Naïve hope or realistic clinical potential?
by: Foster, Jonathan, et al.
Published: (2009)

Diet and Alzheimer's disease
by: Creegan, R., et al.
Published: (2013)

The dynamics of CD147 in Alzheimer's disease development and pathology
by: Kanyenda, L., et al.
Published: (2011)

Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
by: Burnham, S., et al.
Published: (2016)

Changes in Brain Transcripts Related to Alzheimer’s Disease in a Model of HFE Hemochromatosis are not Consistent with Increased Alzheimer’s Disease Risk
by: Johnstone, D., et al.
Published: (2012)

Molecular Genetics of Alzheimer's Disease
by: Verdile, Giuseppe, et al.
Published: (2009)

Alzheimer's disease talk
by: The Star,
Published: (2012)

Associative learning in a mouse model of Alzheimer’s disease
by: Armstrong, Paul
Published: (2017)

Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer’s disease
by: R., Zakaria, et al.
Published: (2017)

Lipopolysaccharide-Induced Memory Impairment in Rats: a Model of Alzheimer’s Disease
by: R., Zakaria, et al.
Published: (2017)

SFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease
by: Warrier, Sudha, et al.
Published: (2016)

Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies
by: Martins, R., et al.
Published: (2018)

Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer’s disease
by: Goozee, K., et al.
Published: (2015)

Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011)

Research criteria for the diagnosis of Alzheimer’s disease: genetic risk factors, blood biomarkers and olfactory dysfunction
by: Foster, Jonathan, et al.
Published: (2008)

The role of endocannabinoids in Alzheimer's disease
by: Maroof, Nazia
Published: (2013)

Consumption of fish and Alzheimer's Disease
by: Newton, Wendy, et al.
Published: (2011)

A study of the neurodegenerative mechanisms of Alzheimer’s and Huntington’s diseases
by: Parry, Nicholas
Published: (2016)

An overview of in vitro research models for Alzheimer`s disease (AD)
by: Makena Ntimi, Carolindah, et al.
Published: (2013)

Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
by: Lui, J., et al.
Published: (2010)

Association of Cardiovascular Factors and Alzheimer's Disease Plasma Amyloid-beta Protein in Subjective Memory Complainers
by: bates, K., et al.
Published: (2009)

Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier
by: Asih, P., et al.
Published: (2017)

Charles Bonnet Syndrome: A Precursor To Alzheimer Disease
by: Janaki V.,, et al.
Published: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rda95q1e4sqkn5cbitjur2u4qh